How variations in snake venom affect antivenom efficacy; new insights from the Indian Institute of Science

How variations in snake venom affect antivenom efficacy; new insights from the Indian Institute of Science


snake venom There is extreme diversity in both structure and capacity, with variations not only occurring between different species but also within the same species. This variability can be attributed to a number of factors, including geographic location and the developmental stage of the snake. Recent studies from the Evolutionary Vinomics Lab Indian Institute of Science This sheds light on how venom potency varies between young and adult Russell’s vipers and spectacled cobras, and how these differences affect venom efficacy. antivenom,
The composition and potency of snake venom can vary considerably depending on geographic location. For example, antivenoms available in India may effectively neutralize venom in one region, but fail to do so in another region, even if the venom is from the same species. This geographic variation poses a challenge to creating universal antivenoms.

Variation in toxicity of venom at different stages of a snake’s life

A recent study sheds light on how venom toxicity changes with the age of the snake. The researchers found that:

  • Russell Viper: Newborns have a more potent venom than adults, showing twice the potency against mammals and ten times more potency against reptiles such as lizards. This increased potency in young vipers may be a defense mechanism, compensating for their smaller size and less effective hunting abilities compared to adults.

  • Spectacled Cobra: The venom of spectacled cobras remains relatively stable throughout the different stages of their lives. This stability is probably due to their varied diet throughout their lives, which does not require changes in venom composition.

Methodology for studying snake venom

The study involved several important steps to analyze venom toxicity and antivenom effectiveness. The researchers began by breeding 194 Russell vipers and 32 spectacled cobras in captivity. Venom samples were collected every three months to monitor changes over time. These venom samples were then tested on various animals, including mice, lizards, and insects, to evaluate their effects. The performance of commercially available antivenom drugs was also evaluated to determine their effectiveness in neutralizing the venoms.

conclusions and implications

  • Poison Potency: The study found significant differences in venom toxicity depending on the age of the snake. For Russell’s vipers, newborns produce a clearly more toxic venom than adults. This increased potency may serve as a defensive adaptation and a means to compensate for their smaller size and less developed predatory skills. In contrast, adult Russell’s vipers, which primarily target larger prey such as rodents, display a venom with lower toxicity against smaller animals such as lizards. On the other hand, the venom of spectacled cobras remains the same throughout their lives. This consistency is likely due to their broad diet, which does not require changes in venom composition.

  • Antivenom Efficacy: Current antivenoms demonstrate efficacy in vitro, but show limited success in real-world snakebite scenarios. This discrepancy may be due to differences in venom potency at different life stages or regional variations in venom composition. In India, antivenoms are typically made from venoms obtained from Tamil Nadu, but they may not be equally effective against all regional venom variations. For example, antivenoms for the Russell viper and the spectacled cobra may vary in their effectiveness depending on the region and the developmental stage of the snake.

Need for region-specific and developmental stage-specific antivenom

According to the study, there is a pressing need to develop antivenom drugs that are specifically designed to address regional venom variations and different developmental stages of the venom. snakeSuch a targeted approach is expected to enhance treatment efficacy and reduce the incidence of treatment failures. Future research should focus on incorporating venoms from different developmental stages into antivenom formulations and rigorously evaluating their effectiveness.
While efforts to develop universal antivenoms are ongoing, achieving this goal remains complex due to the diverse composition of snake venoms. Incorporating venom from young snakes into antivenom formulations could potentially improve treatment outcomes. However, this approach requires further evaluation based on the frequency and severity of bites from young snakes. Overall, the study underscores the importance of integrating both biogeographical and ontogenetic factors into antivenom development to enhance treatment effectiveness and better manage snakebite incidents.
Read this also | How do deep sea creatures survive under extreme pressure?




Comments

No comments yet. Why don’t you start the discussion?

    Leave a Reply

    Your email address will not be published. Required fields are marked *